SDHB and SDHA Immunohistochemistry in Canine Pheochromocytomas

• Published in: Animals (Basel) Vol. 10; no. 9; p. 1
• Main Authors: Abed, Firas M, Brown, Melissa A, Al-Mahmood, Omar A, Dark, Michael J
• Format: Journal Article
• Language: English
• Published: MDPI AG 01-09-2020; MDPI
• Subjects: dog; Dog diseases; Immunohistochemistry; Neuroendocrine tumors; pheochromocytoma; Physiological aspects; SDH; United States
• ISSN: 2076-2615; 2076-2615
• DOI: 10.3390/ani10091683

Pheochromocytomas (PCs) are tumors arising from the chromaffin cells of the adrenal glands and are the most common tumors of the adrenal medulla in animals. In people, these are highly correlated to inherited gene mutations in the succinate dehydrogenase (SDH) pathway; however, to date, little work has been done on the genetic basis of these tumors in animals. In humans, immunohistochemistry has proven valuable as a screening technique for SDH mutations. Human PCs that lack succinate dehydrogenase B (SDHB) immunoreactivity have a high rate of mutation in the SDH family of genes, while human PCs lacking succinate dehydrogenase A (SDHA) immunoreactivity have mutations in the SDHA gene. To determine if these results are similar for dogs, we performed SDHA and SDHB immunohistochemistry on 35 canine formalin-fixed, paraffin-embedded (FFPE) PCs. Interestingly, there was a loss of immunoreactivity for both SDHA and SDHB in four samples (11%), suggesting a mutation in SDHx including SDHA. An additional 25 (71%) lacked immunoreactivity for SDHB, while retaining SDHA immunoreactivity. These data suggest that 29 out of the 35 (82%) may have an SDH family mutation other than SDHA. Further work is needed to determine if canine SDH immunohistochemistry on PCs correlates to genetic mutations that are similar to human PCs.